Bone mineral density in relation to oral contraceptive use;Kostná denzita vo vzt'ahu k užívaniu hormonálnej antikoncepcie

Osteologicky Bulletin

Volumn 9, Issue 4, 2004, Pages 116-120

  Sojákova, Monika ^a   Payer, J ^b   Borovsky M ^a   Killinger, Z ^c   Hruzikova P ^b   Stenova E ^c   Ondrejka, P ^d  

^a UK a Fakultnej Nemocnice   (Slovakia)

^b Int Oddelenie Fakultnej Nemocnice   (Slovakia)

^c NsP Ministerstva Vnútra ^*  (Slovakia)

^d NsP Ministerstva vnútra SR   (Slovakia)

Author keywords

Body mass index; Bone mineral density; Oral contraceptive pills

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CHILDBIRTH; CHRONIC DISEASE; CLIMACTERIUM; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR FRACTURE; FRACTURE; HUMAN; INTERVIEW; LUMBAR SPINE; ORAL CONTRACEPTION; OSTEOPOROSIS; PATHOPHYSIOLOGY; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 11244343323     PISSN: 12113778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lindsay R, Tohme JF, Kanders, B. The effect of oral contraceptive use on vertebral bone mass in premenopausal and postmenopausal women. Contraception 1986;34:333-40.
2. Michaelsson K, Baron, JA, Farahmand BY, et al. Oral contraceptive use and risk of hip fracture: a case-control study. Lancet 1999;353:1481-84.
3. Gambacciani M, Ciaponi M, Cappagli B, et al. Longitudinal evaluation of perimenopausal femoral bone loss: Effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Osteoporosis Int 2000;11:544-8.
4. Polatti F, ferotti F, Filippa N, et al. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 1995;51:221-4.
5. Hartard M, Bottermann P, Bartenstein P, et al. Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity. Contraception 1997;55:87-90.
6. Prior JC, Kirkland SA, Lawrence J, et al. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ 2001;165:1023-9.
7. Karck U, Breckwoldt M. Low-dose oral contraception and bone density. Ther Umsch 2001;58:547-51.
8. Corson SL. Oral contraceptives for the prevention of Osteoporosis. J Reprod Med 1993;38:1015-20.
9. DeCherney A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol 1996;174:15-20.
10. Sojáková M, Payer J, Borovský M. Vplyv hormonálnej antikoncepcie na kostnú denzitu. Prakt. Gynek. 2002;3:120-3.
11. Payer J, Hrúziková P. Osteoporóza. Gynekol. Prax. 2003;1:40-4.
12. Rodin A, Chapman M, Fogelman I. Bone density in users of combined oral contraception. Br J Farn Plann 1991;16:125-9.
13. Mazess RB, Barden HS. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills. Am J Clin Nutr 1991;53:132-42.
14. Volpe A, Silferi M, Genazzani AD, Genazzani AR. Contraception in older women. Contraception 1993;47:229-39.
15. Nappi C, Di Spiezio SA, Acunzo G, et al. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception 2003;67:355-9.
16. Cooper C, Hannaford P, Croft P, Kay CR. Oral contraceptive pill use and fractures in women: a prospective study. Bone 1993;14:41-5.
17. Vessey M, Mant J, Painter R. Oral contraception and other factors in relation to hospital referral for fracture - findings in a large cohort study. Contraception 1998;57:231-5.
18. Horsman A, Jones M, Francis R, Nordin C. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med 1993;309:1405-7.
19. Kuohung W, Borgatt L, Stubblefield P, Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception 2000;61:77-82.